French Personal Products Stock News

Cegedim (ENXTPA:ALCGM) has reported its FY 2025 first half with revenue of €322.5 million, basic EPS of €0.09, and net income of €1.2 million, setting a mixed backdrop for investors weighing profitability against recent losses. The company has seen revenue move from €319.0 million in the first half of 2024 to €322.5 million in the latest half, while EPS shifted from €0.05 to €0.09 over the same period, with trailing 12 month figures still showing a loss of €14.2 million on €658.0 million of...

Recent performance snapshot for Arkema Arkema (ENXTPA:AKE) has drawn fresh attention after a mixed run for shareholders, with the stock showing a 4.5% gain over the past day but a 14.2% decline over the past year. Over the past week the share price return is 15.2%, while the past month shows a 3.4% decline and the past 3 months a 14.1% gain, leaving year-to-date performance at 11.2%. See our latest analysis for Arkema. With the share price at €58.2, Arkema has seen strong short term share...

DBV Technologies (ENXTPA:DBV) has put fresh numbers on the table for FY 2025, with third quarter revenue of US$2.8 million and a basic EPS loss of US$0.24 alongside a net income loss of US$33.2 million. Together, these figures provide a clear snapshot of where the business stands today. Over recent quarters, the company has reported revenue of US$0.5 million in Q4 2024, US$0.8 million in Q1 2025, US$1.5 million in Q2 2025 and US$2.8 million in Q3 2025. Over the same period, quarterly EPS has...

Valeo (ENXTPA:FR) is investing $225 million in a new manufacturing facility in Texas. The plant will produce central compute units for General Motors' software-defined vehicles. The project supports one of the largest orders in Valeo's history and expands its US footprint. For investors watching the auto technology space, this move places Valeo more firmly among the suppliers building the electronics behind software-defined vehicles. The Texas facility connects directly to Valeo's existing...

Dassault Aviation société anonyme (ENXTPA:AM) has drawn investor attention after recent trading left the shares around €310, with mixed returns, including a decline over the past month and gains over the past 3 months and longer periods. See our latest analysis for Dassault Aviation société anonyme. At a share price of €310, Dassault Aviation société anonyme has recently given back some ground, with a 30 day share price return of a 9.88% decline. This comes even though the 90 day share price...

If you are wondering whether Dassault Systèmes at €16.61 is starting to look like value, you are not alone. This article is designed to help you frame that question clearly. The stock has seen a 3.5% decline over the last 7 days, a 7.9% decline over the last 30 days, a 29.0% decline year to date, and a 53.7% decline over the last year, with a 55.3% decline over 3 years and 54.5% decline over 5 years. These sustained declines have put valuation firmly in focus for many investors, who are...

What recent performance tells you about Nanobiotix Nanobiotix (ENXTPA:NANO) has drawn fresh attention after recent price moves, with the stock showing a 1.9% gain over the past day, a small decline over the past week, and double digit returns over the past month and past 3 months. See our latest analysis for Nanobiotix. While the share price has cooled slightly over the past week, the recent 24.9% 1 month share price return sits within a much stronger backdrop. The year to date share price...

Sanofi (ENXTPA:SAN) is back in focus after Japan approved Dupixent for adults with moderate to severe bullous pemphigoid, a rare skin disease. This adds another immunology indication to its portfolio. See our latest analysis for Sanofi. News around Dupixent and other rare disease programs has coincided with a short-term lift, with a 1-day share price return of 1.36% and 7-day share price return of 3.84%, although the 1-year total shareholder return of 16.82% and 3-year total shareholder...

Voltalia (ENXTPA:VLTSA) has drawn attention after recent trading data showed negative returns over the past month and past 3 months. This has prompted investors to reassess the renewable energy producer’s value and risk profile. See our latest analysis for Voltalia. At a share price of €6.56, Voltalia’s recent 7 day and 30 day share price returns of 4.02% and 6.95% declines, alongside a 19.66% year to date decline, point to fading momentum. The 1 year total shareholder return decline of 3.67%...

If you are wondering whether BNP Paribas at €81.87 offers fair value or a potential bargain, this article explores what the current price might imply for you as a shareholder. The stock has recently seen mixed returns, with a 3.1% decline over 7 days and a 13.3% decline over 30 days, while still showing 13.1% over 1 year, 88.7% over 3 years, and 122.1% over 5 years. Recent headlines around BNP Paribas have focused on its position as a major European bank in a sector where investors are...

Amidst heightened uncertainty and inflation risks, the European market has been navigating a challenging landscape, with the STOXX Europe 600 Index recently experiencing a decline of 3.79% due to geopolitical tensions and soaring energy prices. In such an environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment with shareholder interests.

Buyback authorization sets near term context for Technip Energies shares Technip Energies (ENXTPA:TE) has put a new €150 million share repurchase program in place, covering up to 5,000,000 shares and splitting planned purchases between cancellation and equity compensation needs. See our latest analysis for Technip Energies. That buyback news lands at a time when Technip Energies’ share price has been firming up, with a 7 day share price return of 9.10% and a year to date share price return of...

Why Vallourec (ENXTPA:VK) is Back on Investor Radars Vallourec (ENXTPA:VK) has drawn fresh attention after recent share price moves, with investors weighing its €3,809 million revenue base and €355 million net income against performance over the month and past 3 months. See our latest analysis for Vallourec. The recent 1-day share price return of 1.86% builds on a 37.29% 3 month share price return, while the 5 year total shareholder return of 135.32% points to momentum that investors are now...

Event context and recent share performance Thales (ENXTPA:HO) shares have softened recently, with a 1-day return showing a 1.8% decline and a 1-month return showing a 3.8% decline, while the past 3 months show a 5.7% gain. See our latest analysis for Thales. At a share price of €241.6, Thales has seen some short term share price pressure, with the 7 day and 1 month share price returns both negative. However, the 3 month share price return and 3 year and 5 year total shareholder returns remain...

Innate Pharma (ENXTPA:IPH) has just posted its FY 2025 first half numbers, with revenue of €4.86 million and a basic EPS loss of €0.25, alongside net income excluding extra items of a €21.34 million loss. Over the last three reported halves, revenue has moved from €12.35 million in 1H 2024 to €7.78 million in 2H 2024 and €4.86 million in 1H 2025. Basic EPS losses were €0.31, €0.30 and €0.25 respectively. This provides a clearer view of how top line and per share losses have tracked as the...

This article examines whether Carrefour at €15.55 represents fair value or a potential bargain by exploring what the current price may be implying about the business. The stock has returned 1.7% over the last week, 7.9% year to date and 29.1% over the past year, while the 30-day return is a 3.6% decline and the 3- and 5-year returns are 1.1% and 28.0% respectively. Recent coverage around Carrefour has focused on the group as a major European food retailer, with investors weighing its...

Renault and its partners have completed a large scale public trial of V2X collision prevention technology in Bordeaux. The trial focused on smart mobility and safety in a live public transport setting. The consortium is now in commercial discussions to bring this V2X solution to market. For investors watching ENXTPA:RNO, this development comes with the share price at €28.17 and a mixed return profile. The stock is up 3.1% over the past week but shows declines of 13.6% over 30 days and 22.5%...

Arverne Group (ENXTPA:ARVEN) has reported its FY 2025 first half results with revenue of €9.1 million and basic EPS of €0.25 loss, alongside a net income loss of €10.0 million. The company has seen revenue move from €4.5 million in the first half of FY 2024 to €9.1 million in the first half of FY 2025, while net income loss widened from €8.4 million to €10.0 million over the same period, and EPS went from a €0.21 loss to a €0.25 loss. For investors, that combination of higher revenue and...

VINCI (ENXTPA:DG) has been selected to lead infrastructure works for a major fusion energy project in the UK. The company has also secured contracts to upgrade river infrastructure in southern France, focused on sustainable transport and resilience. These contracts expand VINCI's role in complex energy and environmental projects across two core European markets. VINCI operates across concessions, construction and energy services, with projects that span transport, utilities and complex...

ABC arbitrage SA ( EPA:ABCA ) just released its latest yearly report and things are not looking great. Results look to...

It's been a good week for Prodways Group SA ( EPA:ALPWG ) shareholders, because the company has just released its...

If you are looking at Eurazeo and wondering whether the current share price reflects its true value, this article walks through the key signals to help you frame that question. The stock closed at €38.92, with returns of 2.7% decline over the past week, 19.0% decline over the past month, 25.4% decline year to date, and 43.5% decline over the past year. These moves may change how you think about both risk and opportunity around this name. Recent coverage has focused on how such sustained...

Quadient (ENXTPA:QDT) has opened FY 2026 with first half revenue of €517 million and basic EPS of €0.60, setting the tone for how its transition phase is feeding through to the income statement. Over the recent reporting periods, the company has seen revenue move from €534 million in H1 2025 to €558.6 million in H2 2025, with EPS shifting from €0.74 to €1.20 over the same stretch, while trailing 12 month EPS for H1 2026 sits at €1.80. The latest print gives investors a fresh read on how...

How LNA Santé’s FY 2025 Numbers Set the Stage for the Next Chapter LNA Santé (ENXTPA:LNA) has just put fresh numbers on the table, with first half FY 2025 revenue at €446.4 million and basic EPS of €1.10, giving investors a clearer view of how the year is shaping up. The company’s reported revenue moved from €389.6 million and EPS of €1.21 in the first half of FY 2024 to €416.9 million and EPS of €0.92 in the second half, before reaching the latest €446.4 million and €1.10. Trailing twelve...